Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leukine in Alzheimer's Disease
NCT01409915Phase 2Completed
- Sponsor
- University of Colorado Denver
- Start
- Mar 2011
- Primary completion
- Dec 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of sargramostim in Alzheimer's disease (AD), sponsored by University of Colorado Denver. Started Mar 2011; status: completed.
02
Drugs
sargramostim
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT01409915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01409915.